吡柔比星(THP)心脏毒性的国外研究概况

被引：22

作者：

黄慧强

郝东磊

机构：

[1] 中山医科大学肿瘤防治中心内科!广州市

[2] 深圳万乐药业有限公司学术部

来源：

关键词：

心脏毒性; 剂量; 发生率; 用药量; THP; 蒽环类药物; 抗癌药物; 吡柔比星; 吡喃阿霉素;

D O I：

暂无

中图分类号：

R979.1 [抗肿瘤、抗癌药物];

学科分类号：

摘要：

引用

页码：74 / 76

页数：3

共 8 条

[1] AdriamycinCardiotoxicity :Asurveyof 12 73patients. PragaC,BerettaG,VigoP,etal. CancerTreatRep . 1979
[2] Doxorubicin -inducedconges tiveheartfailureinadults. HaqMM,LeghaSS,ChoksiJ,etal. Cancer . 1985
[3] AnorientedphaseⅡtrialofTHP -Adriamycininbreastcarcinoma. MatheG,UmezawaH,OkaS,etal. Biochemcal Pharmacology . 1986
[4] RiskfactorsforDoxorubicin -inducedcongestiveheartfailure. VonHoffD,LayardM,BasaP,etal. Annals of Internal Medicine . 1979
[5] Earlyassessmentofanewanticancerdruganalogue -arethehistoricalcomparisonsobsolete ?TheFrenchExperiencewithPirarubicin. HeraitP,PoutignatN,MartyM,etal. European Journal of Cancer . 1992
[6] Epirubicincar diotoxicity :astudyof 13 5 patientswithadvancedbreastcancer. NielsenD,JensenJ,DombernowskyP,etal. JClinOncol . 1990
[7] Acomparisonofpirarubicinwithotheranthracyclinesonthecardiovascularsystem. AgataN,HiranoS,HaraY,etal. Pharmacomet rics . 1991
[8] Comparisonofcardiotoxici tyofpirarubicin ,epirubicinanddoxorubicinintherat. HiranoS,WakazonoK,AgataN,etal. DrugExpClinRes . 1994